Medtronic ADAPT study results published in The Lancet Diabetes & Endocrinology show improved glycemic control and treatment satisfaction among those using MiniMed™ 780G system¹, compared to insuli...
First-of-its-kind study demonstrates individuals using the Medtronic system achieved 1.4% absolute reduction in A1c and 27.6% absolute increase in...
Kendra Cassillo Ohad Cohen Prnewswire Medtronic Ryan Weispfenning Exchange Commission Drug Administration
Source: businessinsider.com